251 related articles for article (PubMed ID: 17517063)
21. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
22. Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E.
Lefèvre M; Felmlee DJ; Parnot M; Baumert TF; Schuster C
PLoS One; 2014; 9(4):e95550. PubMed ID: 24751902
[TBL] [Abstract][Full Text] [Related]
23. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.
Zhang F; Sodroski C; Cha H; Li Q; Liang TJ
Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511
[TBL] [Abstract][Full Text] [Related]
24. Cellular metabolism of triglyceride-rich lipoproteins: role of heparan sulfate, lipoprotein lipase and lipoprotein receptors.
Sehayek E; Eisenberg S
Z Gastroenterol; 1996 Jun; 34 Suppl 3():110-2. PubMed ID: 8767482
[No Abstract] [Full Text] [Related]
25. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of cell infection with hepatitis C virus (HCV)--a new paradigm in virus-cell interaction.
Budkowska A
Pol J Microbiol; 2009; 58(2):93-8. PubMed ID: 19824391
[TBL] [Abstract][Full Text] [Related]
27. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.
Bürgel B; Friesland M; Koch A; Manns MP; Wedemeyer H; Weissenborn K; Schulz-Schaeffer WJ; Pietschmann T; Steinmann E; Ciesek S
J Viral Hepat; 2011 Aug; 18(8):562-70. PubMed ID: 20579278
[TBL] [Abstract][Full Text] [Related]
29. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein.
Catanese MT; Graziani R; von Hahn T; Moreau M; Huby T; Paonessa G; Santini C; Luzzago A; Rice CM; Cortese R; Vitelli A; Nicosia A
J Virol; 2007 Aug; 81(15):8063-71. PubMed ID: 17507483
[TBL] [Abstract][Full Text] [Related]
30. Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.
Calattini S; Fusil F; Mancip J; Dao Thi VL; Granier C; Gadot N; Scoazec JY; Zeisel MB; Baumert TF; Lavillette D; Dreux M; Cosset FL
J Biol Chem; 2015 Sep; 290(38):23173-87. PubMed ID: 26224633
[TBL] [Abstract][Full Text] [Related]
31. A potential role of the heparan sulfate in the hepatitis C virus attachment.
Heo TH
Acta Virol; 2008; 52(1):7-15. PubMed ID: 18459830
[TBL] [Abstract][Full Text] [Related]
32. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
[TBL] [Abstract][Full Text] [Related]
33. Scavenger receptor class B type I mediates cell entry of hepatitis C virus.
Jia ZS; Du DW; Lei YF; Wei X; Yin W; Ma L; Lian JQ; Wang PZ; Li D; Zhou YX
J Int Med Res; 2008; 36(6):1319-25. PubMed ID: 19094442
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus entry: an intriguing challenge for drug discovery.
Meanwell NA
Curr Opin Investig Drugs; 2006 Aug; 7(8):727-32. PubMed ID: 16955684
[TBL] [Abstract][Full Text] [Related]
35. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM
Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773
[TBL] [Abstract][Full Text] [Related]
36. Studying HCV cell entry with HCV pseudoparticles (HCVpp).
Bartosch B; Cosset FL
Methods Mol Biol; 2009; 510():279-93. PubMed ID: 19009269
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
38. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection.
Yoshida T; Takayama K; Kondoh M; Sakurai F; Tani H; Sakamoto N; Matsuura Y; Mizuguchi H; Yagi K
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):119-24. PubMed ID: 22093821
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors.
Mann WA; Meyer N; Berg D; Greten H; Beisiegel U
Atherosclerosis; 1999 Jul; 145(1):61-9. PubMed ID: 10428296
[TBL] [Abstract][Full Text] [Related]
40. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants.
Catanese MT; Ansuini H; Graziani R; Huby T; Moreau M; Ball JK; Paonessa G; Rice CM; Cortese R; Vitelli A; Nicosia A
J Virol; 2010 Jan; 84(1):34-43. PubMed ID: 19828610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
